The importance of morphometric parameters in differentiating benign/reactive urothelial cells from low-grade urothelial carcinoma: computer-assisted study on urine specimens

Authors

DOI:

https://doi.org/10.26641/1997-9665.2020.4.101-107

Keywords:

morphometry, urothelial carcinoma, urine, cytology

Abstract

Background. Urine cytology is deemed a sensitive method in detection of high-grade urothelial carcinoma. In contrast, detection of low-grade urothelial carcinoma (LGUC) and its differentiation from reactive lesions is difficult with urinary cytology. Objective. Our study aims to determine the effectiveness of morphometric parameters in differentiating reactive urothelial cells from LGUC by cytological examination of urine specimens. Methods. Voided urine samples were used for the study, while the cases were randomized into two groups: those diagnosed with LGUC (first group; N=10) and those which were not diagnosed with LGUC (second group; N=10). The morphometric parameters of major nuclear diameter (MaND), minor nuclear diameter (MiND), mean nuclear area (MNA), cell diameter (CD), mean cell area (MCA), as well as MaND/CD, MiND/CD, MiND/MaND and MNA/MCA ratios were measured on 100 urothelial cells for each case through ScopeImage® 9.0 software. Results. A statistically significant difference was found between the mean values of MiND/CD (p=0.017) and MNA/MCA (p=0.002) ratios of groups. The mean value of both parameters in the first group constituted 0.2 and higher, and below 0.2 in the second group. Conclusion. The ratios of MiND/CD and MNA/MCA in urothelial cells proved significantly higher in patients with LGUC than benign/reactive cases. The reliability of these findings in differentiating LGUC from benign/reactive lesions needs to be verified through studies examining a large number of cases. These parameters can be assessed much faster through a special software enabling an automatic measurement and thus can be used in routine cytological examination.

References

  1. Barkan GA, Wojcik EM, Nayar R, Savic-Prince S, Quek ML, Kurtycz DF, Rosenthal DL. The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology. Acta Cytol. 2016;60(3):185-97. PMID: 27318895; doi: 10.1159/000446270
  2. McCroskey Z, Kliethermes S, Bahar B, Barkan GA, Pambuccian SE, Wojcik EM. Is a consistent cytologic diagnosis of low-grade urothelial carcinoma in instrumented urinary tract cytologic specimens possible? A comparison between cytomorphologic features of low-grade urothelial carcinoma and non-neoplastic changes shows extensive overlap, making a reliable diagnosis impossible. J Am Soc Cytopathol. 2015;4(2):90-7. PMID: 31051715; doi: 10.1016/j.jasc.2014.10.006
  3. Jackson J, Barkan GA, Kapur U, Wojcik EM. Cytologic and cystoscopic predictors of recurrence and progression in patients with low-grade urothelial carcinoma. Cancer Cytopathol. 2013;121(7):398-402. PMID: 23364860; doi: 10.1002/cncy.21272
  4. Önal B, Han Ü, Yilmaz S, Köybasioglu F, Altuğ U. The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer--institutional experience and review. Diagn Cytopathol. 2015;43(4):307-14. PMID: 25488052; doi: 10.1002/dc.23239
  5. Ogura K, Fukuzawa S, Habuchi T, Ogawa O, Yoshida O. Correlation of nuclear morphometry and immunostaining for p53 and proliferating cell nuclear antigen in transitional cell carcinoma of the bladder. Int J Urol. 1997;4(6):561-6. PMID: 9477184; doi: 10.1111/j.1442-2042.1997.tb00309.x
  6. Blomjous CE, Vos W, Schipper NW, Uyterlinde AM, Baak JP, de Voogt HJ, Meijer CJ. The prognostic significance of selective nuclear morphometry in urinary bladder carcinoma. Hum Pathol. 1990;21(4):409-13. PMID: 2318482; doi: 10.1016/0046-8177(90)90203-h
  7. Helander K, Kirkhus B, Iversen OH, Johansson SL, Nilsson S, Vaage S, Fjordvang H. Studies on urinary bladder carcinoma by morphometry, flow cytometry, and light microscopic malignancy grading with special reference to grade II tumours. Virchows Arch A Pathol Anat Histopathol. 1985;408(2-3):117-26. PMID: 3936256; doi: 10.1007/BF00707976
  8. van der Poel HG, Boon ME, Kok LP, van der Meulen EA, van Caubergh RD, de Bruijn WC, Debruyne FM. Morphometry, densitometry and pattern analysis of plastic-embedded histologic material from urothelial cell carcinoma of the bladder. Anal Quant Cytol Histol. 1991;13(5):307-15. PMID: 1801828
  9. Sowter C, Sowter G, Slavin G, Rosen D. Morphometry of bladder carcinoma: definition of a new variable. Anal Cell Pathol. 1990;2(4):205-13. PMID: 2275868
  10. Ramos D, Ruiz A, Morell L, Navarro S, Villamón R, Gil-Salom M, Llombart-Bosch A. Prognostic value of morphometry in low grade papillary urothelial bladder neoplasms. Anal Quant Cytol Histol. 2004;26(5):285-94. PMID: 15560535
  11. Sowter C, Slavin G, Sowter G, Rosen D, Hendry W. Morphometry of bladder carcinoma: morphometry and grading complement each other. Anal Cell Pathol. 1991;3(1):1-9. PMID: 2001332
  12. Blomjous CE, Schipper NW, Vos W, Baak JP, de Voogt HJ, Meijer CJ. Comparison of quantitative and classic prognosticators in urinary bladder carcinoma. A multivariate analysis of DNA flow cytometric, nuclear morphometric and clinicopathological features. Virchows Arch A Pathol Anat Histopathol. 1989;415(5):421-8. PMID: 2508302; doi: 10.1007/BF00747743
  13. Krüger S, Müller H. Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas. Br J Urol. 1995;75(4):480-4. PMID: 7788260; doi: 10.1111/j.1464-410x.1995.tb07269.x
  14. Ozer E, Yörükoğlu K, Mungan MU, Ozkal S, Demirel D, Sağol O, Kirkali Z. Prognostic significance of nuclear morphometry in superficial bladder cancer. Anal Quant Cytol Histol. 2001;23(4):251-6. PMID: 11531139
  15. Lipponen PK, Collan Y, Eskelinen MJ, Pesonen E, Sotarauta M. Morphometry in human transitional cell bladder cancer. Nuclear area and standard deviation of nuclear area--relation to tumor grade (WHO) and prognosis. Eur Urol. 1990;17(2):155-60. PMID: 2311640
  16. Pich A, Chiusa L, Comino A, Navone R. Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinomas. Virchows Arch. 1994;424(2):143-8. PMID: 7910097; doi: 10.1007/BF00193493
  17. De Sanctis PN, Concepcion NB, Tannenbaum M, Olsson C. Quantitative morphometry measurements of transitional cell bladder cancer nuclei as indicator of tumor aggression. Urology. 1987;29(3):322-4. PMID: 3824735; doi: 10.1016/0090-4295(87)90083-5
  18. Kefeli M, Yildiz L, Aydin O, Baris S, Kandemir B. [Nuclear morphometry in typing and grading urothelial neoplasms of urinary bladder]. Turk Patoloji Derg. 2007;23(1):16-20. Turkish. URL http://www.turkjpath.org/pdf/pdf_TPD_170.pdf
  19. Kern WH. The cytology of transitional cell carcinoma of the urinary bladder. Acta Cytol. 1975;19(5):420-8. PMID: 1058612
  20. Bishop JW, Sims KL. Cellular morphometry in nongynecologic thin-layer and filter cytologic specimens. Anal Quant Cytol Histol. 1998;20(4):257-67. PMID: 9739408
  21. Manna AK, Sarkar M, Bandyopadhyay U, Chakrabarti S, Pathak S, Sarkar DK. Cytological and morphometric study of urinary epithelial cells with histopathological correlation. Indian J Surg. 2014;76(1):26-30. PMID: 24799780; PMCID: PMC4006014; doi: 10.1007/s12262-012-0596-3
  22. Boon ME, Kurver PH, Baak JP, Ooms EC. Morphometric differences between urothelial cells in voided urine of patients with grade I and grade II bladder tumours. J Clin Pathol. 1981;34(6):612-5. PMID: 6166638; PMCID: PMC493629; doi: 10.1136/jcp.34.6.612
  23. Murphy WM. Current status of urinary cytology in the evaluation of bladder neoplasms. Hum Pathol. 1990;21(9):886-96. PMID: 2203672; doi: 10.1016/0046-8177(90)90171-z
  24. Bittinger A, Barth P, von Keitz A, Thomas C. Urinary bladder nuclear cytology: results of karyometric investigations. Verh Dtsch Ges Pathol. 1993;77:209-12. PMID: 7511282
  25. van der Poel HG, Boon ME, van Stratum P, Ooms EC, Wiener H, Debruyne FM, Witjes JA, Schalken JA, Murphy WM. Conventional bladder wash cytology performed by four experts versus quantitative image analysis. Mod Pathol. 1997;10(10):976-82. PMID: 9346176
  26. Raab SS, Lenel JC, Cohen MB. Low grade transitional cell carcinoma of the bladder: cytologic diagnosis by key features as identified by logistic regression analysis. Cancer. 1994;74(5):1621-6. PMID: 8062194; doi: 10.1002/1097-0142(19940901)74:5<1621::aid-cncr2820740521>3.0.co;2-e
  27. Shin BK, Lee YS, Jeong H, Lee SH, Kim H, Kim A, Kim I, Kim HK. Detecting malignant urothelial cells by morphometric analysis of ThinPrep® liquid-based urine cytology specimens. Korean J Cytopathol. 2008;19(2):136-43. doi: 10.3338/kjc.2008.19.2.136
  28. Ohsaki H, Hirakawa E, Kagawa K, Nakamura M, Kiyomoto H, Haba R. Value of computer-assisted quantitative nuclear morphometry for differentiation of reactive renal tubular cells from low-grade urothelial carcinoma. Cytopathology. 2010;21(5):334-8. PMID: 20105210; doi: 10.1111/j.1365-2303.2009.00731.x

Downloads

Published

2021-09-25

How to Cite

Musayev, J., Metilli, N., Sholan, R., Hasanov, A., Damirli, A., & Bakhshaliyeva, K. (2021). The importance of morphometric parameters in differentiating benign/reactive urothelial cells from low-grade urothelial carcinoma: computer-assisted study on urine specimens. Морфологія / Morphologia / Morfologìâ, 14(4), 101–107. https://doi.org/10.26641/1997-9665.2020.4.101-107

Issue

Section

Статті